Literature DB >> 7989954

ESHAP chemotherapy for relapsed/refractory non-Hodgkin's lymphoma.

J W Sweetenham, P W Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989954

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Efficacy of ESHAP Regimen in Transplant Ineligible Patients With Relapsed/Refractory T-Cell Lymphoma.

Authors:  Lalita Norasetthada; Adisak Tantiworawit; Thanawat Rattanathammethee; Chatree Chai-Adisaksopha; Thanapat Chaipoh; Ekarat Rattarittamrong
Journal:  J Hematol       Date:  2018-11-22

2.  Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.

Authors:  Ki Hyang Kim; Young Don Joo; Chang Hak Sohn; Ho Jin Shin; Joo Seop Chung; Goon Jae Cho; Sung Hoon Shin; Yang Soo Kim; Won Sik Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 3.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.